Back to
UBS Group AG
INDP4 quarters
Position history for
UBS Group AG's holdings in INDAPTUS THERAPEUTICS INC
Yes. Ubs holds 478 shares of INDP (Indaptus Therapeutics), worth $1,434, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$1,434
Current Shares
478
Total Value Change
-$7
Total Shares Change
-24
Quarter-by-Quarter History
Other major holders of INDP: HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC